Literature DB >> 7371014

Cellular potentials of normal and cancerous fibroblasts and hepatocytes.

R Binggeli, I L Cameron.   

Abstract

Several lines of investigation point to differences in electrical properties between normal and cancerous cells. Several tumor lines have low-resting membrane potentials. A few comparisons have been made between normal and tumor cells within the same tissue cell type. This study compares the cellular or transmembrane potential of hepatocytes and fibroblasts in both normal and tumor cells. High-impedance micropipets were used to record intracellularly in vivo in Buffalo rat hepatocytes and Morris 7777 hepatoma cells, as well as A/J mouse corneal fibroblasts and poorly differentiated fibrosarcoma cells. Rat hepatocytes had a mean membrane potential of -37.1 +/- 4.3 (S.D.) mV compared to -19.8 +/- 7.1 mV in the hepatoma cells. Mouse corneal fibroblasts measured -42.5 +/- 5.4 mV, while cells of mouse fibrosarcoma were -14.3 +/- 5.4 mV. The membrane potentials of the tumor cells were lower in both instances than in their normal counterpart (statistically significant at p = 0.001 for both tissue cell types). This supports the notion that lower cellular or membrane potentials may play a significant role in the altered physiology of the tumor cell.

Entities:  

Mesh:

Year:  1980        PMID: 7371014

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  16 in total

1.  Endogenous Voltage Potentials and the Microenvironment: Bioelectric Signals that Reveal, Induce and Normalize Cancer.

Authors:  Brook Chernet; Michael Levin
Journal:  J Clin Exp Oncol       Date:  2013

2.  Targeting Colon Cancer Cells with Enzyme-Triggered Casein-Gated Release of Cargo from Mesoporous Silica-Based Nanoparticles.

Authors:  Nisitha Wijewantha; Morgan M Eikanger; Ryan M Antony; Rashaun A Potts; Khosrow Rezvani; Grigoriy Sereda
Journal:  Bioconjug Chem       Date:  2021-10-21       Impact factor: 4.774

3.  α5-GABAA receptors negatively regulate MYC-amplified medulloblastoma growth.

Authors:  Soma Sengupta; Shyamal Dilhan Weeraratne; Hongyu Sun; Jillian Phallen; Sundari K Rallapalli; Natalia Teider; Bela Kosaras; Vladimir Amani; Jessica Pierre-Francois; Yujie Tang; Brian Nguyen; Furong Yu; Simone Schubert; Brianna Balansay; Dimitris Mathios; Mirna Lechpammer; Tenley C Archer; Phuoc Tran; Richard J Reimer; James M Cook; Michael Lim; Frances E Jensen; Scott L Pomeroy; Yoon-Jae Cho
Journal:  Acta Neuropathol       Date:  2013-11-07       Impact factor: 17.088

Review 4.  Disrupting proton dynamics and energy metabolism for cancer therapy.

Authors:  Scott K Parks; Johanna Chiche; Jacques Pouysségur
Journal:  Nat Rev Cancer       Date:  2013-09       Impact factor: 60.716

Review 5.  Roles of K+ channels in regulating tumour cell proliferation and apoptosis.

Authors:  Zhiguo Wang
Journal:  Pflugers Arch       Date:  2004-03-27       Impact factor: 3.657

6.  Magneto-electric nanoparticles to enable field-controlled high-specificity drug delivery to eradicate ovarian cancer cells.

Authors:  Rakesh Guduru; Ping Liang; Carolyn Runowicz; Madhavan Nair; Venkata Atluri; Sakhrat Khizroev
Journal:  Sci Rep       Date:  2013-10-16       Impact factor: 4.379

7.  Membrane potential and cancer progression.

Authors:  Ming Yang; William J Brackenbury
Journal:  Front Physiol       Date:  2013-07-17       Impact factor: 4.566

8.  The role of ion channels and transporters in cell proliferation and cancer.

Authors:  Andrea Becchetti; Luca Munaron; Annarosa Arcangeli
Journal:  Front Physiol       Date:  2013-10-29       Impact factor: 4.566

9.  Long-distance communication between laryngeal carcinoma cells.

Authors:  Ieva Antanavičiūtė; Kristina Rysevaitė; Vykintas Liutkevičius; Alina Marandykina; Lina Rimkutė; Renata Sveikatienė; Virgilijus Uloza; Vytenis Arvydas Skeberdis
Journal:  PLoS One       Date:  2014-06-19       Impact factor: 3.240

10.  Transmembrane voltage potential of somatic cells controls oncogene-mediated tumorigenesis at long-range.

Authors:  Brook T Chernet; Michael Levin
Journal:  Oncotarget       Date:  2014-05-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.